These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25921735)

  • 1. The role of complement in membranous nephropathy.
    Ma H; Sandor DG; Beck LH
    Semin Nephrol; 2013 Nov; 33(6):531-42. PubMed ID: 24161038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.
    Dai H; Zhang H; He Y
    Sci Rep; 2015 Mar; 5():8803. PubMed ID: 25740009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-Binding Lectin Deposition in Membranous Nephropathy and Differentiation of Primary from Secondary Forms.
    Zdravkova I; Tilkiyan E; Bozhkova D
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent glomerular PCDH7 deposits in PLA2R-associated membranous nephropathy.
    Fu N; Yuan S; Yang G; Li H; Wang T
    CEN Case Rep; 2024 Aug; 13(4):297-301. PubMed ID: 38145434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of membranous nephropathy with Anti-GBM glomerulonephritis: a case series report.
    Liu G; Feng X; Yu S; Sheng J; Liu C; Wang L
    BMC Nephrol; 2024 Jun; 25(1):204. PubMed ID: 38907217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Beck LH
    Am J Kidney Dis; 2024 May; 83(5):566-568. PubMed ID: 38260930
    [No Abstract]   [Full Text] [Related]  

  • 7. An Unusual Case of Anti-Glomerular Basement Membrane Disease and Phospholipase A
    Eley S; Morales-Alvarez MC; Vanguri VK; Chopra B
    Am J Kidney Dis; 2024 Jan; 83(1):112-115. PubMed ID: 37714285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report.
    Suetsugu R; Sakuma H; Maruyama K; Matsuki M; Ogawa Y; Nakagawa N
    CEN Case Rep; 2024 Apr; 13(2):98-103. PubMed ID: 37421572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syphilis-related Membranous Nephropathy in a 35-year-old Woman.
    Nakayama Y; Yamanouchi M; Mizuno H; Suwabe T; Sekine A; Ikuma D; Hasegawa E; Oba Y; Kono K; Kinowaki K; Ohashi K; Wada T; Sawa N; Ubara Y
    Intern Med; 2024 May; 63(10):1429-1432. PubMed ID: 37839882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment.
    Huang B; Zhang Z; Sui W; Zhao L; Li Y; Feng L; Yang D; Zhou Y
    Genomics; 2024 Mar; 116(2):110796. PubMed ID: 38237745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Mignano SE; Pascal V; Odioemene NE; Forehand W; Javaugue V; Said SM; Sethi S; Sirac C; Nasr SH
    Am J Kidney Dis; 2024 Jul; 84(1):120-125. PubMed ID: 38266972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Honda D; Okunaga I; Omote D; Inoue H; Yamasaki K; Wakabayashi H; Suzuki M; Aizawa M; Tomita S; Ikeda JI; Asanuma K
    Am J Kidney Dis; 2024 Aug; 84(2):250-254. PubMed ID: 38522728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous-like glomerulopathy with masked monotypic IgG deposits: A single center case series.
    Attieh R; Merchant K; Yang Y; Sethna C; Jhaveri KD
    Clin Nephrol; 2024 Aug; 102(2):107-112. PubMed ID: 38836365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy.
    Rovira J; Arana C; Garcia-Busquets A; Gille I; Quintana LF; Heemskerk MHM; Heidt S; Palou E; Diekmann F
    Kidney Int; 2024 Jun; 105(6):1320. PubMed ID: 38777405
    [No Abstract]   [Full Text] [Related]  

  • 15. Membranous nephropathy due to malignancy: Is end stage kidney disease an irreversible final route?
    Vida AC; Vieira P; Silva G
    Clin Nephrol; 2024 May; 101(5):260-261. PubMed ID: 38358376
    [No Abstract]   [Full Text] [Related]  

  • 16. (T-) Regulation of Immunity in Membranous Nephropathy.
    Mathew G; Sinha A
    Indian J Pediatr; 2024 Jul; 91(7):657-658. PubMed ID: 38556614
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
    Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
    Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of IgG subtypes in membranous nephropathy: A case report].
    Asmandar S; Figuères ML; Goujon JM; Noël LH; Hummel A
    Nephrol Ther; 2015 Jun; 11(3):169-72. PubMed ID: 25921735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.